Trials / Completed
CompletedNCT01697098
Dexamethasone for Preterm Labour
Dexamethasone Dosing Interval: 12 or 24 Hours Apart? A Randomized,Clinical Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The investigators sought to determine whether the incidence of neonatal respiratory distress syndrome (RDS) in preterm fetuses is similar with 12- vs 24-hour dosing interval of dexamethasone.
Detailed description
The administration of glucocorticoids to accelerate fetal lung maturity in patients with preterm delivery plays an important role for obstetrics and neonatal care. Many studies have shown that maternal administration of glucocorticoids has a significant beneficial effect in decreasing the incidence of respiratory distress syndrome (RDS) in infants delivered at 28-34 weeks of gestation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone 24 hours | |
| DRUG | Dexamethasone 12 |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2012-07-01
- Completion
- 2012-08-01
- First posted
- 2012-10-02
- Last updated
- 2012-10-02
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT01697098. Inclusion in this directory is not an endorsement.